Trials
1 active
7 in total
Targets
—
None known yet
What this is
- How it works
- How it works isn't classified yet
- Tested for
- Pancreatic Ductal Adenocarcinoma
- Main trialPhase 3
- “PURPOSE: This phase III clinical trial evaluates the efficacy and safety of adjuvant Immuncell-LC therapy combined with gemcitabine versus adjuvant gemcitabine single therapy after R0 or R1 resection in patients with pancreatic ductal adenocarcinoma.”In the company’s words, NCT04969731 on ClinicalTrials.gov
- Other names
- Activated T lymphocyte · Autologous activated T lymphocyte
Other drugs for Pancreatic Ductal Adenocarcinoma
- CAM2029Camurus AB · Phase 3
- RYZ101RayzeBio, Inc. · Phase 3
- XNW28012Evopoint Biosciences Inc. · Phase 3
- IvonescimabAkeso · Summit Therapeutics · Phase 3
- DaraxonrasibRevolution Medicines · Phase 3
- IBI343Innovent · Phase 3
Coming up1
- DecPhase 3 trial completes · ClinicalTrials.gov
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials7
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 3Recruiting | Dec 2026 | Safety and Efficacy of Immuncell-LC With Gemcitabine in Resectable Pancreatic Cancer | |
| Phase 3Completed | Oct 2012 | Clinical Trial to Assess the Efficacy and Safety of 'Immuncell-LC' With Temozolomide in Newly Diagnosed Glioblastoma of Korea | |
| Phase 3Completed | Nov 2012 | Efficacy and Safety of Immuncell-LC Group and Non-treatment Group in Hepatocelluar Carcinoma Patients | |
| Phase 2Completed | Dec 2010 | Evaluate the Efficacy and Safety of Activated T-lymphocyte Cell Therapy in Advanced Pancreatic Cancer | |
| Phase 2Completed | Jul 2017 | Efficacy and Safety of 'Immuncell-LC Group' and 'Non-treatment Group' in Nexavar Treated Patients for Advanced HCC | |
| Phase 2Completed | 11 Aug 2020 | Safety and Efficacy of "Immuncell-LC" in TACE Therapy | |
| Phase 1/2Completed | 9 Sep 2021 | Evaluate the Efficacy and Safety of 'Immuncell-LC' in Patients Undergoing Liver Transplantation |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026